# CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage

> **NCT05302856** · NA · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 30 (estimated)

## Conditions studied

- Male Infertility

## Interventions

- **DIAGNOSTIC_TEST:** Blood test (CMV IGG, Anti sperm antibody, Testosterone levels)

## Key facts

- **NCT ID:** NCT05302856
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-02
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05302856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05302856, "CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05302856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*